Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
Sign Up to like & getrecommendations! Published in 2020 at "Cellular Oncology"
DOI: 10.1007/s13402-020-00529-1
Abstract: Background Colorectal cancer (CRC) is a disease with high morbidity and mortality rates. 5-fluorouracil (5-FU) is the first-line recommended drug for chemotherapy in patients with CRC, and it has a good effect on a variety… read more here.
Keywords: pharmacogenomics fluorouracil; colorectal cancer; drug; fluorouracil colorectal ... See more keywords